The use of antibiotics in Italy: National Report - Year 2020
On 10 March 2022, the 'National Report on the Use of Antibiotics in Italy -2020' was presented on AIFA's YouTube channel.
23 March 2022
On 10 March 2022, the 'National Report on the Use of Antibiotics in Italy -2020' was presented on AIFA's YouTube channel.
On 30 November 2021, AIFA defined the new access criteria for Law 326/2003. This law was supplemented by the Law of 10 November 2021
AIFA has set up a Scientific Committee for the Surveillance of Vaccines against COVID-19 that will remain in office for two years. On the board you can read the
With the Ministerial Decree of 5/5/2020, the new National Commission for the updating of the Essential Levels of Care (LEA) was established. The commission remains in office for three
The COVID19 Technical and Scientific Committee (STC) supporting the Government was updated on 18 April 2020 Who are its members? [DISCLAIMER: not to be
Law 326/2003 established a national fund financed by 5% of pharmaceutical companies' annual expenditure on promotion activities. The 50%
Attention! ART.40 of DECREE-LAW no. 23 of 8 April 2020 'Urgent measures regarding access to credit' repeals ART.17 of the Cura Italia, thus reorganising the
Article 17 of the Cura Italia decree-law states that the national opinion on protocols for the testing of medicines for epidemiological emergencies by COVID is provided, limited to
In these times of the COVID-19 emergency we often hear about the '648/96' list and reimbursed drugs for off-label use... but what does this mean? With
In these quarantine days, Pharma Value wants to share with you some useful content for those working in regulatory and market access and for
